
|Articles|December 3, 2010
Victoza® LEAD Clinical Trial Program
Advertisement
Victoza® studies included nearly 4000 patients in the Liraglutide Effect and Action in Diabetes (LEAD) trials. Click
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Role of the Pharmacist in the Management of Psychosis in Parkinson’s Disease
2
High-Fat Dairy Consumption Linked to Decreased Risk of Dementia
3
RSV Hospitalization Associated With Persistent Symptoms and Reduced Quality of Life in Adults
4
HRS-1780 Demonstrates Positive Safety, Efficacy Treating Patients With CKD
5




